Diabetes Self-Management Blog

Here at Diabetes Flashpoints, we have discussed both how financial conflicts of interest among doctors may affect their behavior and what might be done to remedy the situation. Due to a provision in last year’s Affordable Care Act (“health care reform”), however, the landscape of payments and gifts to doctors is about to change.

Last week, the Centers for Medicare and Medicaid Services (CMS) proposed a new rule, mandated by the Affordable Care Act, that will require pharmaceutical companies and makers of medical supplies and devices to report all payments and gifts to doctors and medical schools in excess of $10. According to an article on the proposed rule at MassDevice.com, the text of the rule states that “while some collaboration is beneficial to the continued innovation and improvement if our health care system, payments… can also introduce conflicts of interest that may influence research, education, and clinical decision-making.” After a comment period lasting until February 17, 2012, CMS plans to issue a final rule, after which companies will be required to begin reporting payments in a number of categories, including consulting or speaking fees, honoraria, gifts, entertainment, food, travel, education, or research grants. Companies must also report any royalties or license payments made to doctors and any “current or prospective ownership or investment interest” of a doctor in the company. Upon collection and review, CMS will make reported data available to the public.

Penalties for failing to report payments include a possible fine of $150,000 per year, or up to $1 million for knowingly concealing payments. As it notes in the proposed rules, CMS hopes that the new reporting requirement will lead companies to rethink some of their payments and gifts, lest a relationship appear inappropriate. Right now, however, it is unclear whether or how the new rule will change the behavior of companies and doctors. It is possible that some doctors and companies will rethink their relationships, while others will calculate that not enough of their patients pay attention to gifts and payments for these transactions to negatively affect their image. And, of course, whether a transaction is potentially corrupting is largely in the eye of the beholder.

What do you think — does this proposed rule go far enough in addressing potential conflicts of interest among doctors? Too far? When does a financial relationship between a drug or medical device company and a doctor become inappropriate, and when is it all right? Would you second guess a doctor, or not visit one, based on his or her financial connections to companies? Leave a comment below!

POST A COMMENT       
  

Comments
  1. If I knew that a doctor had close ties to a particular drug company I might consider NOT going to that doctor.

    Posted by Arlene Walker |

Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of Madavor Media, LLC., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.


Flashpoints
Obamacare, Round 2 (09/22/14)
Added Sugars, Added Confusion (09/17/14)
Weight and Diabetes Risk (09/10/14)
Caving to Cravings (09/03/14)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.